These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 13675270

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antagonism between harmaline and longacting monoamine oxidase inhibitors concerning the effect on 5-hydroxytryptamine and norepinephrine metabolism in the brain.
    PLETSCHER A, BESENDORF H.
    Experientia; 1959 Jan 15; 15(1):25-6. PubMed ID: 13619675
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabolism of 5-hydroxytryptamine (serotonin) by monoamine oxidase.
    SJOERDSMA A, SMITH TE, STEVENSON TD, UDENFRIEND S.
    Proc Soc Exp Biol Med; 1955 May 15; 89(1):36-8. PubMed ID: 14384870
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activity of monoamine oxidase in relation to the 5-hydroxytrypatamine and norepinephrine content of the rat brain.
    GEY KF, PLETSCHER A.
    J Neurochem; 1961 Feb 15; 6():239-43. PubMed ID: 13704855
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [On the mechanism of action of amino-oxidase inhibitors. Experiments on serotonin metabolism].
    SCHMID E.
    Chemotherapia (Basel); 1962 Feb 15; 4():255-61. PubMed ID: 14498641
    [No Abstract] [Full Text] [Related]

  • 12. Behavioral effects and brain amine content in rats.
    HESS SM, DOEPFNER W.
    Arch Int Pharmacodyn Ther; 1961 Nov 01; 134():89-99. PubMed ID: 13907003
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour.
    Green AR, Youdim MB, Grahame-Smith DG.
    Neuropharmacology; 1976 Mar 01; 15(3):173-9. PubMed ID: 132619
    [No Abstract] [Full Text] [Related]

  • 15. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. II. 5-Hydroxytryptamine tolerance before and after Nialamide.
    DEWHURST WG, PARE CM.
    J Ment Sci; 1961 Mar 01; 107():244-9. PubMed ID: 13722404
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Inhibition "in vitro" of monoamine oxidase].
    NARANJO R.
    Rev Asoc Medica Mex; 1960 Jun 25; 40():272-9. PubMed ID: 14426018
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [On the influence of alkyl phosphates on the 5-hydroxytryptamine content of the rat brain].
    HEYE D, HILDEBRANDT HJ, SCHWABE U.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1961 Jun 25; 241():197-8. PubMed ID: 13714060
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.